# ATORVASTATIN CALCIUM
> **ANDA205519** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2016-05-19
## Drug
- **FDA Application Number:** ANDA205519
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ATORVASTATIN CALCIUM
- **Generic name:** ATORVASTATIN CALCIUM
- **Active ingredients:** ATORVASTATIN CALCIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SCIEGEN PHARMS
- **Manufacturer:** Cipla USA Inc.,
- **First approval:** 2016-05-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205519)
---
*AI Analytics · CC0 1.0*